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The Burden of Informal Caregivers 
of Alzheimer’s Patients: An 
Estimation to Portugal
Aida Isabel Tavares and Carolina Freitas
Abstract
The demographic phenomenon of ageing is speeding up in Europe. People live 
longer and so the prevalence of dementia increases, including Alzheimer’s disease. 
This is a progressive disease in which people slowly lose their cognitive and physical 
capacities until death takes over. Alzheimer’s disease not only imposes a very high 
burden in the affected person but also inflicts a high and overwhelming burden of the 
caregivers. The carers’ burden includes health deterioration, labour damaging and 
loses and financial and social costs, while the care provided is not well valued. The 
aim of this chapter is to review the main trends and concepts related to ageing, care-
givers and Alzheimer’s disease. It also presents the economic burden associated with 
the disease and the monetary value of the care provided by caregivers in Portugal.
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1. Introduction
Alzheimer’s disease is the most common form of dementia, and it accounts 
for about 60–70% of the 50 million people suffering from dementia worldwide 
[1]. This means that between 30 and 35 million of people suffer from Alzheimer’s 
disease across the world. However, the numbers of those with this disease may be 
underestimated as only about 40–50% of the cases of dementia are identified in 
developed countries [2].
Dementia and, in particular, Alzheimer’s disease are a major reason for the dis-
ability and dependency across older people. The individual impact burden due to this 
disease is broad. It includes physical, psychological, social and economic aftermaths. 
But also the burden is shared with carers, families and society in general [1]. About 
50% of carers say that their own health was affected by the responsibility of caring 
their Alzheimer’s patients despite their positive sentiments about their role [3]. The 
economic repercussions of Alzheimer’s disease are diverse, and they include the direct 
medical costs, the social care costs and the costs of informal care. The magnitude of 
these economic repercussions cannot be ignored neither by society nor by politicians.
The aim of this chapter is of twofold. Firstly, we review the phenomenon of 
ageing and describe the increasing prevalence of Alzheimer’s disease; additionally, 
we highlight the relevance of informal care and the burden supported by informal 
caregivers. Secondly, this chapter aims to describe the social and financial burden of 
informal caregivers of Alzheimer’s patients in Portugal and to estimate a monetary 
value for the care they provide and have to bear.
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The chapter proceeds with a section describing the ageing phenomenon and 
Alzheimer’s disease, as well as the increasing prevalence of this disease. Next, it 
reviews the type of care available to deal with Alzheimer’s patients, and a particular 
emphasis is placed on informal care. In the following section, the socio-economic 
burden of informal caregivers is outlined. The chapter continues with a section 
presenting the estimation of the financial burden of carers of Alzheimer’s patients 
in Portugal followed by a conclusion section.
2. Ageing and the Alzheimer’s disease
The current major demographic phenomenon in Europe is ageing. The share 
of older people in the population is increasing, and the age distribution picture is 
changing to an oval shape, and it is tending to look like a block. The ageing trend 
may be explained by (i) the increased longevity of people, (ii) the declined fertility 
and (iii) the ageing of “baby boom” generations.
In Europe, as the cohort of baby boomers gets older, the wider stripes of the 
pyramid move up in direction of the top of the pyramid. Younger generations 
and their low fertility are reflected by their narrow stripes at the base of the age 
pyramid. As the time goes by, the top highest age group of the pyramid enlarges 
as an increasing large share of very old people who are living longer lives 
(Figure 1) [4].
So life expectancy has been increasing and people are living longer. These longer 
lives may be lived in a healthy status, but most likely the additional years of life are 
lived in unhealthy conditions, in particular, the last years of life. Among the health 
conditions, the most prevalent in older ages is dementia, which includes Alzheimer’s 
disease. This health condition is not a consequence of the ageing natural process, 
but it has a high prevalence among the older group of people [5]. It generates high 
economic and social costs, and for this reason it may be considered as one of the 
great challenges of society nowadays [5].
Figure 1. 
Population age pyramid in Europe.
3The Burden of Informal Caregivers of Alzheimer’s Patients: An Estimation to Portugal
DOI: http://dx.doi.org/10.5772/intechopen.90673
Dementia (and Alzheimer’s disease) is a syndrome, chronic or progressive, 
characterised by an abnormal and fast decline in the ability of people to reason 
and think (the decline of the cognitive function). Although consciousness is not 
affected, the remaining capacities are strongly diminished such as memory, think-
ing, orientation, comprehension, calculation, learning, language and judgement. 
Additionally, there is a decline in the emotional control and social behaviour [1].
Life expectancy for an Alzheimer’s patient, after his diagnosis, is about 10 years. 
There are three stages of progressive gravity of the disease: early (2–4 years), mild 
(2–10 years) and late (1–3 years or more) stages. In the early stage, illness goes 
unnoticed, and its signs include forgetfulness, losing oneself in familiar surround-
ings and losing track of time. As the illness progresses, at the mild stage, the signs 
become clear, and patients begin to forget recent events and people’s names, forget 
where they are, have difficulty communicating with others, need help with personal 
care and start to show behavioural changes as wandering and repeat questioning. 
When the last stage is reached, Alzheimer’s patients are inactive and dependent. 
Their memories are seriously damaged and physical signs are obvious.
The clinical dementia rating (CDR) is the clinical instrument that measures the 
severity of dementia, including Alzheimer’s disease. This instrument evaluates six 
domains of cognitive and functional performance of patients, including memory, 
orientation, judgement and community affairs. This instrument scores the patients 
impairment in five levels so that medical intervention is more adequate and effective.
CDR is not a clinical diagnosis; it rather is a measurement scale that helps the 
diagnosis of Alzheimer’s disease. In fact, there is no single test that provides a 
consistent diagnosis of Alzheimer’s disease. The diagnosis is a process of careful 
evaluation done by a multidisciplinary team which may include neurologists, geri-
atricians, nurses, psychologists and psychiatrists [6].
In Western Europe, in 2016, it has been estimated that 4,499,078 disability-
adjusted life years (DALY) were attributed to Alzheimer’s dementia disease 
[7]. Mortality associated to Alzheimer’s disease has been increasing in Europe 
(Figure 2). Women die more than men, but the rate of increase has been identical 
for both genders. This trend is expected under the current conditions of longer lives 
and advance medical knowledge.
Currently, there are no medicines that prevent Alzheimer’s disease or cure it, and 
so the numbers of patients and deaths will continue to grow, as well as the burden on 
the people suffering the disease, on the caregivers and on the health system as a whole.
3. Informal caregiver and the socio-economic burden
Caring of Alzheimer’s patients may take place in two frameworks, which may be 
supplemental or complementary: the formal care and the informal care.
Figure 2. 
Standardised death rate due to Alzheimer’s disease. Source: Based on Eurostat [hlth_cd_asdr2] [8].
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The formal care is supplied by the public or private sector and by its health-care 
professionals, who provide a service and are paid for that service. Across Europe, 
the number of formal carers is low. In some countries, such as Portugal, the number 
of formal carers is extremely low, less than an average of 2 long-term care (LTC) 
professionals per 100 older persons aged above 65 (Figure 3). While in some 
countries the number of LTC workers per old person has increased between 2011 
and 2016 (as in France and Croatia), in other countries there has been a decrease (as 
in the Netherlands, Estonia and the UK) (Figure 3).
Informal care is offered by someone who is close to the older patient, either fam-
ily, friends or neighbours. Informal carers provide help in a voluntary and non-paid 
manner. Usually caregivers provide assistance to patients in their own home, and 
this assistance is mainly directed for patients’ daily tasks [9].
Despite international data on informal carers is hard to compare and it is based 
in several sources of information, the OECD has gathered the information for 
several countries concerning the share of informal carers among the population 
aged more than 50 (Figure 4) [10].
In spite of being difficult to find numbers for informal carers along the time and 
across countries, it is expected that this number will not be sufficient to attend to 
the increased number of dependent older people [11].
The total cost of dementia in EU27 in 2008 was estimated in round number of 
$160 billion, and 56% of these are costs of informal care. While in Northern Europe 
the larger proportion goes for formal care, in Southern Europe the larger share is on 
the informal care [12].
The importance of informal care has become a more prominent issue recently, 
as the share of elderly in the population began to increase and as the LTC system 
funding began to be a social concern. Not only informal care is a cost-effective 
alternative, but also it is a well-being alternative for patients who may remain at 
their homes. So in several countries across Europe, different public supports have 
been offered to informal care as a form of incentive and as a support to families and 
friends of patients. That being so the distinction between formal and informal and 
paid and unpaid care is becoming unclear in European countries [13].
Informal care is provided at home, and it basically aims to help Alzheimer’s 
patients in activities of daily living (ADLs) and instrumental activities of daily 
living (IADLs) but also to give emotional support. ADLs are activities that include 
Figure 3. 
The number of LTC workers per 100 individuals aged +65, 2011 and 2016 (or nearest year). Note: LTC,  
long-term care. Source: OECD [9].
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basic self-care tasks such as walking, toileting, bathing, feeding and dressing. IADLs 
are self-care activities, which require some complex thinking, skills and organisa-
tion. These include managing finance, transportation, shopping, meal preparation, 
communication and managing medications.
Helping with these activities systematically along time is uncomfortable, 
unpleasant and overwhelming. Informal caregiving is emotionally rewarding, 
bringing up self-esteem and sense of worthiness and life mission. But it is a very 
demanding role, and informal carers very often suffer burnout and health problems 
[14]. On top of this, several carers have difficulties combining the care with their 
labour responsibilities, and some quit their jobs to be able to respond the patient 
needs. In fact, this decision may be harmful in their future as it compromises future 
employability and leads to permanent drop-out from the labour market [15].
Several studies have been devoted to estimate the cost of taking care of 
Alzheimer’s patients. In general, these costs depend on the number of hours of care, 
the severity degree of the disease, the use of formal care and the weather the carer is 
cohabiting with the patient [16].
The most used methods to estimate the monetary value of informal care to 
Alzheimer’s patients are those based on “stated preferences” and those based on 
revealed preferences, which include the “proxy-good method” (also called market 
cost method) and the “opportunity cost method” [17].
“Stated preferences” is a method to provide a monetary value to something that 
has no market value. It is based on questions collected by a survey. The answers are 
given in the form of monetary amounts, choices, ratings or other scales which allow 
the monetary value.
The “proxy-good method” values time spent on informal care at the market prices 
of a close market substitute. So an almost perfect substitute in the market needs to be 
found and used as a reference. The “opportunity cost method” values the informal 
caregiver’s benefit forgone due to spending time on providing informal care. Usually 
this is done using the individual’s wage rate. Both these methods do not cover all 
costs and effects of informal care, and so they are usually used as complements [17]. 
However, in our work due to the data availability, only “proxy-good method” is used.
Figure 4. 
Informal carers as a % of total population, EQLS 2016. Source: EQLS 2016, figure adapted from EQLS 
overview report [10].
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Concerning the care provided, data is collected using the instrument called 
Resource Utilization in Dementia (RUD), which provides information relative to the 
formal and informal care given to the patient according to his level of dementia [18].
4. Estimation of the burden of carers in Portugal
It has been estimated that the number of people with dementia in Portugal, in 
2012, was 182,526 in a population of less than 10 million people. This number rep-
resents about 1.7% of Portuguese population, and it is higher than the EU averages 
of 1.55% [19] (Alzheimer Europe 2019). Considering that 60–70% of those patients 
with dementia suffer from Alzheimer’s disease, it means that currently there are 
more than 110,000–128,000 Alzheimer’s patients in Portugal. It is estimated that in 
the next 20 years, the number of Alzheimer’s patients in this country will be around 
322,000 [9].
The current health expenditure (CHE) in Portugal directed for long-term care 
(LTC) has two functions, both social and health. Despite the inexistence of the EU 
average reference and comparing with Sweden which has some well-functioning 
long-term care system, Portugal presents a low share of expenditure (CHE) in 
long-term care expenditure for health but a reasonable level for long-term care 
expenditure for social support (Figure 5).
Public aid to informal caregivers in Portugal is in its infant stages, and the formal 
care is insufficient for the current demand. This national institutional framework 
pushes nearly all the care of Alzheimer’s patients to their families, who have stood 
for the overwhelming task of taking care of them, even if they do it with affection 
and love or even if they have no conditions to do so.
4.1 Method for collecting data
To collect data for Portugal, a questionnaire based on RUD, which includes 
questions about the informal caregiver concerning their socio-demographic char-
acteristics, health status, received external support, professional status, activities 
performed and time management, was used [20].
This questionnaire was applied over 5 months, in 2018, in the Neurology 
Services of the Hospital Centre of the University of Coimbra, Portugal, to informal 
caregivers of Alzheimer’s patients. This study has been approved by the ethical com-
mission of the hospital centre, and participants have signed an informed consent 
form. Confidentiality and anonymity are guaranteed to participants in this study.
Figure 5. 
Share of LTC expenditure in total current health expenditure. Note: LTC, long-term care expenditure.  
Source: Based on Eurostat [hlth_sha11_hc] [8].
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The study includes 86 Alzheimer’s patients and 97 informal caregivers. The differ-
ence in these numbers is due to the fact that some patients have more than one carer.
4.2 Descriptive results
Alzheimer’s patients were on average 75 years old, and about 60% were women; 
around 28% were in the very early stage of the disease, 28% were in the mild stage, 
20% were in the moderate stage and, finally, about 24% were in the severe stage.
Informal caregivers were on average 60 years old, and the majority of them 
(about 67%) were women, 53.6% of carers live in the same home as the patient, 
50.5% are spouses, ad more than 60% of carers reported suffering some health 
problem; and nearly 50% reported being professionally inactive, the remaining 
share of carers reported being absent from work for about 4 days a year to comply 
with the patient needs, and 70% of them report penalties in terms of salary and day 
off reduction and hour replacement from these work absences.
Lastly, it must be highlighted that 90% of the carers have no public financial 
support, and so all expenses are supported privately, by the patient, by the carer or 
by the family budget.
4.3 Estimated monetary costs
The results concerning the costs and monetary values relatively to the informal 
caregivers are expressive and informative for policymakers. From the point of 
view of the cost with health care supported by caregivers, data shows that the total 
amount spent annually is almost 590€ or almost 50€ a month. These costs are 
reported by caregivers (Table 1).
From the different activities performed by caregivers for their patients, data 
obtained from the questionnaire unveil that the activities that absorb the highest 
share of daily hours are the activities of daily living (ADL), such as toilet visits, eating, 
dressing, grooming, walking and bathing, and the instrumental activities of daily 
living (IADL), such as shopping, food preparation, housekeeping, laundry, transpor-
tation, taking medication and managing financial matters and supervision (Figure 6).
Finally, according to hours of care provided for the Alzheimer’s patient, the 
total average annual monetary value of those hours may be estimated. Taking into 
account the average number of daily hours of care and the monetary value of each 
hour (the value is estimated using the proxy-good method), the total average annual 
value of care sums up to 14,152.32 euros (Table 2). The values may vary according to 
the level of severity of the disease. At the most severe level of severity, these values 
decrease because there is an increasing share of burden with formal care.
Type of annual average costs Monetary value €
Emergency care 9.00
Consultations 51.58
Diagnostic tests 65.78
Medication 469.08
Total annual average costs 586.44
Total monthly average costs 48.87
Source: Freitas [20].
Table 1. 
Annual average costs supported by informal carers.
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Summing up, the burden taken by an Alzheimer’s patient caregiver includes the 
costs related to labour absence, to the lack of social activities and to health deterio-
ration which may be reflected in health-care costs or untreated health conditions. 
These health-care costs were valued by 586.44€ average a year, even though caregiv-
ers seldom find time to look after themselves.
On the other hand, the caregivers provide care which was estimated to value 
over an average of 14,100€ per year, mainly resulting from daily activities and 
supervision activities. However, these values may be underestimated. On the one 
hand, caregivers tend to under-report the time spent providing care; on the other 
hand, the proxy-good method does not account for all cost, and it undervalues some 
activities, because they are associated with low labour market qualifications.
5. Conclusion
Undoubtedly one of the great challenges of society nowadays is to deal and 
to manage the increasing trend of Alzheimer’s patients in families as well as its 
associated increasing burden in the suffering individuals, in their caregivers and in 
society in general.
The care provided to Alzheimer’s patients may be formal or informal. In the 
latter case, it is provided by family, neighbours and friends in the patient home. The 
burden imposed on carers is heavy. It includes health deterioration, labour negative 
impacts, inexistent social life and a cost of the time spent helping the patient with 
their daily activities and supervising their actions.
In this chapter, the burden and value of caregivers of Alzheimer’s patients in 
Portugal were estimated and presented. The values may be underestimated, but 
they serve as a floor cost reference for policymakers. Several measures may be 
Average Numbers Total Early 
stage
Mild stage Moderate 
stage
Severe 
stage
No. of daily hours 10.8 9.7 10.5 11.8 11.7
Daily cost € 45.36 40.74 44.10 49.56 49.14
Days of week 6 5.7 6 6.3 6.3
Week cost (7 days) € 272.16 232.22 264.60 312.23 309.58
Annual cost (52 weeks) € 14,152.32 12,075.34 13,759.20 16,235,86 16,098.26
Source: Freitas [20].
Table 2. 
Monetary value for care given by the informal carer.
Figure 6. 
Distribution of daily hours across activities. Source: Freitas [20].
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undertaken in order to alleviate the burden supported by these carers. For instance, 
substitute carers, supplied by the health or social system, could coordinate tasks 
and daily help so that the caregiver himself could have more time to do other 
things such as go medical consultations, sleep and perform other social activities. 
Another measure that would be welcome is to provide a complementary subsidy 
for the patient expenditures in medical treatment and formal care. In this way, the 
caregiver budget would be protected, and it could be used on the carer’s own needs. 
Informal care is an increasing substitute and complement of formal care, and it 
should be valued from a societal perspective. Caregivers must be looked after and 
protected for their valuable contribution to society.
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